Patent · US Active

Hepatitis C virus inhibitors

US7772183B2 · kind B2 · utility

12Cited by

0References

19Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

David J. Carini · Wilmington, US
Barry Johnson · Castle Rock, US
Zhizhen Barbara Zheng · Cheshire, US
Stanley D'Andrea · Middletown, US
Paul Michael Scola · Glastonbury, US

Key dates

Filing date	Oct 11, 2006
Grant date	Aug 10, 2010
Priority date	—
Expiry date	Dec 3, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/0827
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Hepatitis C virus inhibitors having the general formulaare disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.